BS
Babita Saxena
About Babita Saxena
Data last updated:
Babita Saxena is a Director at Glucolabs Healthcare Private Limited (since 2021). The company operates in Pharma. Glucolabs Healthcare Private Limited reported revenue of ₹80.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Feb 2021 | 2021 | ₹80.3 Lakh (FY 2025) | Active |
Board colleagues of Babita Saxena
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepak Sharma | 09265909 | Glucolabs Healthcare Private Limited | Additional Director |
| Orikolodatte Perinchery Ravindran Nair | 09615358 | Glucolabs Healthcare Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Babita Saxena
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Babita Saxena
Babita Saxena currently holds 1 directorship: Glucolabs Healthcare Private Limited (Director, since 03 Feb 2021, revenue ₹80.3 Lakh (FY 2025)).
Babita Saxena was first appointed on 03 Feb 2021 as Director at Glucolabs Healthcare Private Limited.
The current boards of Babita Saxena's companies include Deepak Sharma (Glucolabs Healthcare Private Limited), Orikolodatte Perinchery Ravindran Nair (Glucolabs Healthcare Private Limited).